Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             268 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absolute Bioavailability of Intranasal Fluticasone Furoate in Healthy Subjects Allen, Ann
2007
29 Supplement A p. 1415-1420
6 p.
artikel
2 Abuse Potential of Carisoprodol: A Retrospective Review of Idaho Medicaid Pharmacy and Medical Claims Data Owens, Christopher
2007
29 Supplement A p. 2222-2225
4 p.
artikel
3 A case of early onset and late recognition of Fabry disease with generalized lymphadenopathy, anorchidism, hypergonadotropic hypogonadism, and growth retardation Sozin, S.E.
2007
29 Supplement A p. S27-S28
2 p.
artikel
4 A case of Fabry disease with multiple sclerosis Bonometti, M.A.
2007
29 Supplement A p. S27-
1 p.
artikel
5 Achievement of optimal combined lipid values in a managed care setting: Is a new treatment paradigm needed? Sarawate, Chaitanya A.
2007
29 Supplement A p. 196-209
14 p.
artikel
6 Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus Kinsley, Brendan
2007
29 Supplement A p. S153-S160
8 p.
artikel
7 A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients McCollum, Marianne
2007
29 Supplement A p. 469-477
9 p.
artikel
8 A comparison of three questionnaire-based measures of analgesic use over 11 years in adult males: A retrospective analysis of data from a prospective, population-based cohort study Ademi, Zafina
2007
29 Supplement A p. 529-534
6 p.
artikel
9 Acute Hepatitis Attack After Exposure to Telithromycin Onur, Ozge
2007
29 Supplement A p. 1725-1729
5 p.
artikel
10 Acute NSAID-related transmural duodenitis and extensive duodenal ulceration Hashash, Jana G.
2007
29 Supplement A p. 2448-2452
5 p.
artikel
11 Acute Pancreatitis in a Patient Treated with Micafungin Sato, Ken
2007
29 Supplement A p. 1468-1473
6 p.
artikel
12 A disease-specific measure of health-related quality of life in adults with chronic Immune Thrombocytopenic Purpura: Psychometric testing in an open-label clinical trial Mathias, Susan D.
2007
29 Supplement A p. 950-962
artikel
13 Adoption of new antiglaucoma drugs in finland: Impact of changes in copayment Martikainen, Jaana E.
2007
29 Supplement A p. 2468-2476
9 p.
artikel
14 A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin Rogers, Sophie L.
2007
29 Supplement A p. 242-252
11 p.
artikel
15 Advancing Therapy in Type 2 Diabetes Mellitus with Early, Comprehensive Progression from Oral Agents to Insulin Therapy Vinik, Aaron
2007
29 Supplement A p. 1236-1253
18 p.
artikel
16 Adverse drug interactions involving common prescription and over-the-counter analgesic agents Hersh, Elliot V.
2007
29 Supplement A p. 2477-2497
21 p.
artikel
17 Allergic Rhinitis: The Impact of Discordant Perspectives of Patient and Physician on Treatment Decisions Meltzer, Eli O.
2007
29 Supplement A p. 1428-1440
13 p.
artikel
18 A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets Lachaine, Jean
2007
29 Supplement A p. 519-528
10 p.
artikel
19 Analgesic efficacy of celecoxib in postoperative oral surgery pain: A single-dose, two-center, randomized, double-blind, active- and placebo-controlled study Cheung, Raymond
2007
29 Supplement A p. 2498-2510
13 p.
artikel
20 An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: Results from the losartan intervention for endpoint reduction (LIFE) study adapted to The Netherlands Boersma, Cornelis
2007
29 Supplement A p. 963-971
artikel
21 An Evaluation of patients' preferences for osteoporosis medications and their attributes: The PREFER-international study Duarte, Jesús Walliser
2007
29 Supplement A p. 488-503
16 p.
artikel
22 A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers Bladh, Nina
2007
29 Supplement A p. 640-649
10 p.
artikel
23 An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis Ousler III, George W.
2007
29 Supplement A p. 611-616
6 p.
artikel
24 Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: A retrospective database study Yurgin, Nicole
2007
29 Supplement A p. 316-325
10 p.
artikel
25 Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the united states, 1996–2003: National estimates and associated factors Sankaranarayanan, Jayashri
2007
29 Supplement A p. 723-741
19 p.
artikel
26 A Phase III Extension Study of Aldurazyme®(Laronidase) in Mucopolysaccharidosis I Clarke, L.A.
2007
29 Supplement A p. S111-
1 p.
artikel
27 A phase i, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults Swearingen, Dennis
2007
29 Supplement A p. 617-625
9 p.
artikel
28 A population-based analysis of statin utilization in British Columbia Raymond, Colette B.
2007
29 Supplement A p. 2107-2119
13 p.
artikel
29 A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain Moberly, James B.
2007
29 Supplement A p. 399-412
14 p.
artikel
30 A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis Breuer, Brenda
2007
29 Supplement A p. 2022-2030
9 p.
artikel
31 A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain Beaulieu, André D.
2007
29 Supplement A p. 49-60
12 p.
artikel
32 A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults Park, Kyungsoo
2007
29 Supplement A p. 154-162
9 p.
artikel
33 A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers Tsai, Shih-Tzu
2007
29 Supplement A p. 1027-1039
13 p.
artikel
34 A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia Jeffres, Meghan N.
2007
29 Supplement A p. 1107-1115
9 p.
artikel
35 A Retrospective Evaluation of the Use of Gabapentin and Pregabalin in Patients with Postherpetic Neuralgia in Usual-Care Settings Gore, Mugdha
2007
29 Supplement A p. 1655-1670
16 p.
artikel
36 A review of combination therapy in patients with benign prostatic hyperplasia McVary, Kevin T.
2007
29 Supplement A p. 387-398
12 p.
artikel
37 A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms Kanabar, Dipak
2007
29 Supplement A p. 2716-2723
8 p.
artikel
38 A review of the clinical efficacy and safety of 5α-reductase inhibitors for the enlarged prostate Naslund, Michael J.
2007
29 Supplement A p. 17-25
9 p.
artikel
39 A Review of the Literature on Osteonecrosis of the Jaw in Patients with Osteoporosis Treated with Oral Bisphosphonates: Prevalence, Risk Factors, and Clinical Characteristics Pazianas, Michael
2007
29 Supplement A p. 1548-1558
11 p.
artikel
40 A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers Monif, Tausif
2007
29 Supplement A p. 2677-2684
8 p.
artikel
41 Assessing antibodies to α-galactosidase A in fabry disease Richards, Susan M.
2007
29 Supplement A p. S7-S8
2 p.
artikel
42 Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study Adachi, Jonathan D.
2007
29 Supplement A p. 2055-2067
13 p.
artikel
43 Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial Song, Yeong Wook
2007
29 Supplement A p. 862-873
artikel
44 Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: A longitudinal, retrospective, cohort study Ye, Xin
2007
29 Supplement A p. 2748-2757
10 p.
artikel
45 Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV Townsend, Mary L.
2007
29 Supplement A p. 711-716
6 p.
artikel
46 Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin Schindler, Christoph
2007
29 Supplement A p. 172-176
5 p.
artikel
47 “Atypical variant” and an indirect diagnosis of fabry disease in a patient with end-stage renal disease Ciabattini, F.
2007
29 Supplement A p. S26-S27
2 p.
artikel
48 A 2-Week, Crossover Study to Investigate the Effect of Fluticasone Furoate Nasal Spray on Short-Term Growth in Children with Allergic Rhinitis Gradman, Josefine
2007
29 Supplement A p. 1738-1747
10 p.
artikel
49 A 2-Week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain Choi, Chan-Bum
2007
29 Supplement A p. 1381-1389
9 p.
artikel
50 A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in african american and hispanic american patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy Davidson, Jaime A.
2007
29 Supplement A p. 1900-1914
15 p.
artikel
51 A 6-Week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004% Maul, Eugenio
2007
29 Supplement A p. 1915-1923
9 p.
artikel
52 A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler Murphy, Kevin
2007
29 Supplement A p. 1013-1026
14 p.
artikel
53 A 12-Week, Prospective, Open-Label Analysis of the Effect of Rosuvastatin on Triglyceride-Rich Lipoprotein Metabolism in Patients with Primary Dyslipidemia Kostapanos, Michael S.
2007
29 Supplement A p. 1403-1414
12 p.
artikel
54 A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL) Tytus, Richard H.
2007
29 Supplement A p. 305-315
11 p.
artikel
55 Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: A randomized, double-blind, 2-way crossover in healthy male thai volunteers Boonleang, Jutima
2007
29 Supplement A p. 703-710
8 p.
artikel
56 Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: Two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects Palma-Aguirre, Jose Antonio
2007
29 Supplement A p. 1146-1152
7 p.
artikel
57 Bioequivalence of Two Commercial Preparations of trimethoprim/sulfamethoxazole: A randomized, single-dose, single-blind, crossover trial Alonso Campero, Rosalba
2007
29 Supplement A p. 326-333
8 p.
artikel
58 Buprenorphine Transdermal Delivery System in Adults with Persistent Noncancer-Related Pain Syndromes Who Require Opioid Therapy: A Multicenter, 5-Week Run-in and Randomized, Double-Blind Maintenance-of-Analgesia Study Landau, Craig J.
2007
29 Supplement A p. 2179-2193
15 p.
artikel
59 Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A 12-Week, Multicenter, Randomized, Double- Blind, Double-Dummy, Placebo- and Active-Controlled Trial Nelson, Harold S.
2007
29 Supplement A p. 2167-2178
12 p.
artikel
60 Cholesterol reduction yields clinical benefits: meta-analysis including recent trials Gould, A. Lawrence
2007
29 Supplement A p. 778-794
artikel
61 Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy Tilling, Lindsey
2007
29 Supplement A p. 352-356
5 p.
artikel
62 Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: The role of comparative studies and implications for future studies Cosman, Felicia
2007
29 Supplement A p. 1116-1127
12 p.
artikel
63 Clinical perspectives in the prevention and treatment of chronic nephropathy, including an overview of the DEMAND Study Remuzzi, Giuseppe
2007
29 Supplement A p. S64-S72
9 p.
artikel
64 Clinical practice and guidelines in Europe for the treatment of hypertension, with a focus on patients with diabetes mellitus Zanchetti, Alberto
2007
29 Supplement A p. S44-S53
10 p.
artikel
65 Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: A 23-day, prospective, double-blind, randomized, parallel-group study Rodriguez, René Fernando
2007
29 Supplement A p. 581-587
7 p.
artikel
66 Community-phenotype-methicillin-resistant staphylococcus aureus infections: A retrospective chart review of outcomes after treatment with daptomycin Katz, David E.
2007
29 Supplement A p. 2440-2447
8 p.
artikel
67 Comorbidity of diabetes mellitus and hypertension in the clinical setting: A review of prevalence, pathophysiology, and treatment perspectives Bretzel, Reinhard G.
2007
29 Supplement A p. S35-S43
9 p.
artikel
68 Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: A Monte Carlo simulation analysis Noreddin, Ayman M.
2007
29 Supplement A p. 2685-2689
5 p.
artikel
69 Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: A 16-week, randomized, open-label, parallel-group trial conducted in russia Ushakova, Olga
2007
29 Supplement A p. 2374-2384
11 p.
artikel
70 Comparison of Botulinum Neurotoxin Preparations for the Treatment of Cervical Dystonia Chapman, Mary Ann
2007
29 Supplement A p. 1325-1337
13 p.
artikel
71 Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: A retrospective, nonrandomized, open-label, historical chart review Lorente, Leonardo
2007
29 Supplement A p. 2433-2439
7 p.
artikel
72 Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study Lewin, Andrew
2007
29 Supplement A p. 844-855
artikel
73 Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen Rascati, Karen L.
2007
29 Supplement A p. 1203-1213
11 p.
artikel
74 Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults Antonijoan, Rosa
2007
29 Supplement A p. 814-822
artikel
75 Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: An 8-week, multicenter, randomized, open-label, dose-titration study in korean patients with hypercholesterolemia Hak Lee, Sang
2007
29 Supplement A p. 2365-2373
9 p.
artikel
76 Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: A single-center, randomized, double-blind, two-period, crossover trial in Japan Hirao, Koichi
2007
29 Supplement A p. 927-934
artikel
77 Comparison of usability and patient preference for the new disposable insulin device solostar versus flexpen, lilly disposable pen, and a prototype pen: an open-label study Haak, Thomas
2007
29 Supplement A p. 650-660
11 p.
artikel
78 Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: A double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults Pool, James L.
2007
29 Supplement A p. 61-73
13 p.
artikel
79 Comparisons of Rosiglitazone Versus Pioglitazone Monotherapy Introduction and Associated Health Care Utilization in Medicaid-Enrolled Patients with Type 2 Diabetes Mellitus Balkrishnan, Rajesh
2007
29 Supplement A p. 1306-1315
10 p.
artikel
80 Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's Disease Chen, Jack J.
2007
29 Supplement A p. 1825-1849
25 p.
artikel
81 Cost-Effectiveness of a Lidocaine 5% Medicated Plaster Relative to Gabapentin for Postherpetic Neuralgia in the United Kingdom Dakin, Helen
2007
29 Supplement A p. 1491-1507
17 p.
artikel
82 Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: A European model based on the CLARITY and COMMIT trials Berg, Jenny
2007
29 Supplement A p. 1184-1202
19 p.
artikel
83 Cost-Effectiveness of Irbesartan 300 mg Given Early Versus Late in Patients with Hypertension and a History of Type 2 Diabetes and Renal Disease: A Canadian Perspective Coyle, Douglas
2007
29 Supplement A p. 1508-1523
16 p.
artikel
84 Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada Earnshaw, Stephanie R.
2007
29 Supplement A p. 2096-2106
11 p.
artikel
85 Darunavir: A Nonpeptidic Antiretroviral Protease Inhibitor McCoy, Christopher
2007
29 Supplement A p. 1559-1576
18 p.
artikel
86 Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome—positive acute lymphoblastic leukemia Steinberg, Michael
2007
29 Supplement A p. 2289-2308
20 p.
artikel
87 Deferasirox for Transfusion-Related Iron Overload: A Clinical Review Lindsey, Wesley T.
2007
29 Supplement A p. 2154-2166
13 p.
artikel
88 Desloratadine treatment for intermittent and persistent allergic rhinitis: A review Bachert, Claus
2007
29 Supplement A p. 1795-1802
8 p.
artikel
89 Developing a Pulmonary Insulin Delivery System for Patients with Diabetes Dailey, George
2007
29 Supplement A p. 1271-1283
13 p.
artikel
90 Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg Schreiber, Curtis P.
2007
29 Supplement A p. 2511-2519
9 p.
artikel
91 Diffusion into Use of Exenatide for Glucose Control in Diabetes Mellitus: A Retrospective Cohort Study of a New Therapy Segal, Jodi B.
2007
29 Supplement A p. 1784-1794
11 p.
artikel
92 Diversity of neuropathy in a familywith Fabry disease Møller, A.T.
2007
29 Supplement A p. S24-S25
2 p.
artikel
93 Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model Smits, Kim M.
2007
29 Supplement A p. 691-702
12 p.
artikel
94 Does Statin Therapy Initiation Increase the Risk for Myopathy? An Observational Study of 32,225 Diabetic and Nondiabetic Patients Nichols, Gregory A.
2007
29 Supplement A p. 1761-1770
10 p.
artikel
95 Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study Nurko, Saul
2007
29 Supplement A p. 2010-2021
12 p.
artikel
96 Dosing of insulin glargine in the treatment of type 2 diabetes Barnett, Anthony
2007
29 Supplement A p. 987-999
13 p.
artikel
97 Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies Kajdasz, Daniel K.
2007
29 Supplement A p. 2536-2546
11 p.
artikel
98 Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: A meta-analysis of randomized controlled trials Kang, Sheng
2007
29 Supplement A p. 2406-2418
13 p.
artikel
99 Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial Keith, Paul K.
2007
29 Supplement A p. 419-426
8 p.
artikel
100 Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study Crisafulli, Ernesto
2007
29 Supplement A p. 2001-2009
9 p.
artikel
101 Effect of a single IV administration of l-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: A pilot study Montisci, Roberta
2007
29 Supplement A p. 163-171
9 p.
artikel
102 Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: A prospective, open-label study Pai, Amy Barton
2007
29 Supplement A p. 2699-2705
7 p.
artikel
103 Effect of Miglustat on Bone Disease in Adults with Type 1 Gaucher Disease: A Pooled Analysis of Three Multinational, Open-Label Studies Pastores, Gregory M.
2007
29 Supplement A p. 1645-1654
10 p.
artikel
104 Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: A three-way crossover study Fogari, Roberto
2007
29 Supplement A p. 413-418
6 p.
artikel
105 Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: A randomized, open-label, crossover study in taiwan Tsai, Yuh-Shyan
2007
29 Supplement A p. 670-682
13 p.
artikel
106 Effects of enzyme replacement therapyin Fabry neuropathy Politei, J.M.
2007
29 Supplement A p. S30-S31
2 p.
artikel
107 Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: An exploratory analysis of archived samples using two commercially available techniques Ose, Leiv
2007
29 Supplement A p. 2419-2432
14 p.
artikel
108 Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: A retrospective, nonrandomized autopsy study Chamilos, Georgios
2007
29 Supplement A p. 1980-1986
7 p.
artikel
109 Effects of Milrinone on Contractility and Cyclic Adenosine Monophosphate Production Induced by β1- and β2-Adrenergic Receptor Activation in Human Myocardium Carceles, Mafía D.
2007
29 Supplement A p. 1718-1724
7 p.
artikel
110 Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: A double-blind, randomized, parallel-group study Graff, Jochen
2007
29 Supplement A p. 438-447
10 p.
artikel
111 Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: A prospective, nonrandomized, crossover study in patients coinfected with hepatitis c and hiv receiving methadone maintenance treatment Berk, Steven I.
2007
29 Supplement A p. 131-138
8 p.
artikel
112 Effects of renin-angiotensin system inhibition end-organ protection: Can we do better? Weir, Matthew R.
2007
29 Supplement A p. 1803-1824
22 p.
artikel
113 Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: A multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial Välimäiki, Matti J.
2007
29 Supplement A p. 1937-1949
13 p.
artikel
114 Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial LaForce, Craig
2007
29 Supplement A p. 1579-1590
12 p.
artikel
115 Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study Davidson, Michael H.
2007
29 Supplement A p. 1354-1367
14 p.
artikel
116 Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: A 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study Pytel, Joseph
2007
29 Supplement A p. 84-98
15 p.
artikel
117 Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients Yevtushenko, Valery Y.
2007
29 Supplement A p. 2319-2332
14 p.
artikel
118 Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease Besarab, Anatole
2007
29 Supplement A p. 626-639
14 p.
artikel
119 Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study Biederman, Joseph
2007
29 Supplement A p. 450-463
14 p.
artikel
120 Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis Hale, Martin
2007
29 Supplement A p. 874-888
artikel
121 Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: A randomized, double-blind, active- and placebo-controlled, parallel-group trial Aqua, Keith
2007
29 Supplement A p. 1000-1012
13 p.
artikel
122 Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: A 12-week, multicenter, randomized, double-blind, placebo-controlled study Gibofsky, Allan
2007
29 Supplement A p. 1071-1085
15 p.
artikel
123 Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers Nakamura, Masakazu
2007
29 Supplement A p. 1040-1056
17 p.
artikel
124 Efficacy of Multivitamin Supplementation Containing Vitamins B6 and B12 and Folic Acid as Adjunctive Treatment with a Cholinesterase Inhibitor in Alzheimer's Disease: A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study in Taiwanese Patients Sun, Yu
2007
29 Supplement A p. 2204-2214
11 p.
artikel
125 Efficacy of oral nicorandil in patients with end-stage renal disease: A retrospective chart review after coronary angioplasty in japanese patients receiving hemodialysis Ishii, Hideki
2007
29 Supplement A p. 110-122
13 p.
artikel
126 Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: A randomized, double-blind, placebo-controlled study Ishkanian, Gary
2007
29 Supplement A p. 99-109
11 p.
artikel
127 Empiric therapy for secondary peritonitis: A pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation Eagye, Kathryn J.
2007
29 Supplement A p. 889-899
artikel
128 End-stage renal disease in fabry disease Granata, A.
2007
29 Supplement A p. S20-
1 p.
artikel
129 Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin a microemulsion: A randomized, open-label, two-period crossover study in healthy adult male mexican volunteers Piñeyro-López, Alfredo
2007
29 Supplement A p. 2049-2054
6 p.
artikel
130 Evidence-Based Pharmacologic Management of Pulmonary Arterial Hypertension Benedict, Neal
2007
29 Supplement A p. 2134-2153
20 p.
artikel
131 Evidence for selective low leukocyte enzyme activity levels associated with the G1170C>T 5'untranslated polymorphism of the α-galactosidase a gene Ferreira, S.
2007
29 Supplement A p. S28-S29
2 p.
artikel
132 Fabrazyme® therapy in pediatric patients with Fabry disease: Improvements in quality-of-life measures Tylki-Szymanska, A.
2007
29 Supplement A p. S31-S32
2 p.
artikel
133 Fabry disease and bilateral renal cell carcinoma Herrero, J.J.
2007
29 Supplement A p. S28-
1 p.
artikel
134 Fabry disease: classic phenotype in alarge family affected by a novel mutation (A292T) in the α-galactosidase a gene Spanu, C.
2007
29 Supplement A p. S26-
1 p.
artikel
135 Fabry Disease in Pediatrics: The Need for Early Intervention Wijburg, Frits A.
2007
29 Supplement A p. S105-S106
2 p.
artikel
136 Fabry disease model: A rational approach to the management of fabry disease Wanner, Christoph
2007
29 Supplement A p. S2-S5
4 p.
artikel
137 Factors related to antipsychotic oversupply among central Texas Veterans Yang, Min
2007
29 Supplement A p. 1214-1225
12 p.
artikel
138 Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study Simpson, David M.
2007
29 Supplement A p. 588-601
14 p.
artikel
139 Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis Long, Aidan A.
2007
29 Supplement A p. 342-351
10 p.
artikel
140 Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus Danne, Thomas
2007
29 Supplement A p. S145-S152
8 p.
artikel
141 Formation of neutralizing antibodies in patients receiving botulinum toxin type a for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials Yablon, Stuart A.
2007
29 Supplement A p. 683-690
8 p.
artikel
142 Frequency of 5'untranslated region single nucleotide polymorphisms of the α-galactosidase a gene in the Portuguese population Ferreira, S.
2007
29 Supplement A p. S28-
1 p.
artikel
143 Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis Schwid, Steven R.
2007
29 Supplement A p. 2031-2048
18 p.
artikel
144 Getting closer to physiologic insulin secretion Heise, Tim
2007
29 Supplement A p. S161-S165
5 p.
artikel
145 Goserelin Acetate 10.8 mg Plus Iron Versus Iron Monotherapy Prior to Surgery in Premenopausal Women with Iron-Deficiency Anemia Due to Uterine Leiomyomas: Results from a Phase III, Randomized, Multicenter, Double-Blind, Controlled Trial Muneyyirci-Delale, Ozgul
2007
29 Supplement A p. 1682-1691
10 p.
artikel
146 Health Care Costs and Medication Adherence Associated with Initiation of Insulin Pen Therapy in Medicaid-Enrolled Patients with Type 2 Diabetes: A Retrospective Database Analysis Pawaskar, Manjiri D.
2007
29 Supplement A p. 1294-1305
12 p.
artikel
147 Health Care Costs and Mortality for Canadian Urban and Rural Patients with Diabetes: Population-Based Trends from 1993–2001 Pohar, Sheri L.
2007
29 Supplement A p. 1316-1324
9 p.
artikel
148 Health care resource utilization and expenditures associated with the use of insulin glargine Miller, Donald R.
2007
29 Supplement A p. 478-487
10 p.
artikel
149 Heart failure patients' awareness and perceptions of the risk of using NSAIDs: A pilot study Cottrell, Neil
2007
29 Supplement A p. 717-719
3 p.
artikel
150 Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: Case report and review of the literature Mohammadianpanah, Mohammad
2007
29 Supplement A p. 1161-1165
5 p.
artikel
151 Hypertension treatment in a medicare population: Adherence and systolic blood pressure control Fung, Vicki
2007
29 Supplement A p. 972-984
artikel
152 Hypertriglyceridemia and cardiovascular risk reduction Jacobson, Terry A.
2007
29 Supplement A p. 763-777
artikel
153 Identification and Pretherapy Susceptibility of Pathogens in Patients with Complicated Urinary Tract Infection or Acute Pyelonephritis Enrolled in a Clinical Study in the United States from November 2004 Through April 2006 Peterson, Janet
2007
29 Supplement A p. 2215-2221
7 p.
artikel
154 Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy Makus, Ken G.
2007
29 Supplement A p. 334-341
8 p.
artikel
155 Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis Giovannoni, Gavin
2007
29 Supplement A p. 1128-1145
18 p.
artikel
156 Immunophenotyping of glomerular cellsin renal biopsies provides evidence of selective podocyte involvement in Fabry disease Franeta, A.-J.
2007
29 Supplement A p. S21-
1 p.
artikel
157 Impact of treatment with agalsidasebeta on health-related quality of life in patients with Fabry disease Badia, X.
2007
29 Supplement A p. S31-
1 p.
artikel
158 Importance of Observational Studies in Clinical Practice Ligthelm, Robert J.
2007
29 Supplement A p. 1284-1292
9 p.
artikel
159 Influence of Antiretroviral Therapy on Oxidative Stress and Cardiovascular Risk: A Prospective Cross-Sectional Study in HIV-Infected Patients Masiá, Mar
2007
29 Supplement A p. 1448-1455
8 p.
artikel
160 Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: A single-dose, randomized, open-label, two-way crossover study Solans, Anna
2007
29 Supplement A p. 900-908
artikel
161 Influences of Attitudes on Family Physicians' Willingness to Prescribe Long-Acting Opioid Analgesics for Patients with Chronic Nonmalignant Pain Nwokeji, Esmond D.
2007
29 Supplement A p. 2589-2602
14 p.
artikel
162 Inhaled dry powder insulin for the treatment of diabetes mellitus Setter, Stephen M.
2007
29 Supplement A p. 795-813
artikel
163 Interaction Between Warfarin and Cranberry Juice Paeng, Christine H.
2007
29 Supplement A p. 1730-1735
6 p.
artikel
164 Intermitent long-term treatment in a patient with Fabry disease Del Pozo, C.
2007
29 Supplement A p. S32-
1 p.
artikel
165 Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study Finkelstein, Yaron
2007
29 Supplement A p. 2738-2743
6 p.
artikel
166 Lysosomal Storage Disorders—A Vision of the Future Smith, Alan
2007
29 Supplement A p. S74-
1 p.
artikel
167 Management of access to branded psychotropic medications in private health plans Hodgkin, Dominic
2007
29 Supplement A p. 371-380
10 p.
artikel
168 Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison Robbins, David C.
2007
29 Supplement A p. 2349-2364
16 p.
artikel
169 Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy Silva, Matthew
2007
29 Supplement A p. 253-260
8 p.
artikel
170 Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold Kollar, Christine
2007
29 Supplement A p. 1057-1070
14 p.
artikel
171 Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients Kanaan, Abir O.
2007
29 Supplement A p. 2395-2405
11 p.
artikel
172 Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: A sequential, randomized, double-blind clinical trial Derosa, Giuseppe
2007
29 Supplement A p. 602-610
9 p.
artikel
173 Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials Buse, John B.
2007
29 Supplement A p. 139-153
15 p.
artikel
174 Mixed Dyslipidemia Among Patients Using Lipid-Lowering Therapy in French General Practice: An Observational Study Van Ganse, Eric
2007
29 Supplement A p. 1671-1681
11 p.
artikel
175 Mutations in exon 7 of the α-galactosidase a gene Rosenberg, K.
2007
29 Supplement A p. S34-
1 p.
artikel
176 Myxedema coma and cardiac ischemia in relation to thyroid hormone replacement therapy in a 38-year-old Japanese woman Taguchi, Takafumi
2007
29 Supplement A p. 2710-2714
5 p.
artikel
177 Narcotic Drug Use Among Patients with Lower Back Pain in Employer Health Plans: A Retrospective Analysis of Risk Factors and Health Care Services Rhee, YongJoo
2007
29 Supplement A p. 2603-2612
10 p.
artikel
178 Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial Baumgartner, Rudolf A.
2007
29 Supplement A p. 261-278
18 p.
artikel
179 Negative Binomial Meta-Regression Analysis of Combined Glycosylated Hemoglobin and Hypoglycemia Outcomes Across Eleven Phase III and IV Studies of Insulin Glargine Compared with Neutral Protamine Hagedorn Insulin in Type 1 and Type 2 Diabetes Mellitus Mullins, Peter
2007
29 Supplement A p. 1607-1619
13 p.
artikel
180 Nelarabine: A novel purine antimetabolite antineoplastic agent Buie, Larry W.
2007
29 Supplement A p. 1887-1899
13 p.
artikel
181 Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: A retrospective analysis of a randomized, double-blind, double-dummy trial Marple, Bradley F.
2007
29 Supplement A p. 2690-2698
9 p.
artikel
182 Optimizing Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Strategies for Improving Patient-Centered Outcomes Hanania, Nicola A.
2007
29 Supplement A p. 2121-2133
13 p.
artikel
183 Oral Garenoxacin in the Treatment of Acute Bacterial Maxillary Sinusitis: A Phase II, Multicenter, Noncomparative, Open-Label Study in Adult Patients Undergoing Sinus Aspiration Lopez Sisniega, J.
2007
29 Supplement A p. 1632-1644
13 p.
artikel
184 Oral Mucositis-Related Oropharyngeal Pain and Correlative Tumor Necrosis Factor-α Expression in Adult Oncology Patients Undergoing Hematopoietic Stem Cell Transplantation FalI-Dickson, Jane M.
2007
29 Supplement A p. 2547-2561
15 p.
artikel
185 Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial Rog, David J.
2007
29 Supplement A p. 2068-2079
12 p.
artikel
186 Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes Orzeck, Eric A.
2007
29 Supplement A p. 2246-2255
10 p.
artikel
187 Paroxetine and congenital malformations: Meta-Analysis and consideration of potential confounding factors Bar-Oz, Benjamin
2007
29 Supplement A p. 918-926
artikel
188 Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus Chao, Jingdong
2007
29 Supplement A p. 177-180
4 p.
artikel
189 Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects O'Farrell, A. Marie
2007
29 Supplement A p. 1692-1705
14 p.
artikel
190 Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilide fumarate: A phase I, randomized, open-label, increasing-dose study in healthy chinese men Li, Yishi
2007
29 Supplement A p. 1957-1966
10 p.
artikel
191 Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine After a Single Intravenous Administration in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Escher, Monica
2007
29 Supplement A p. 1620-1631
12 p.
artikel
192 Pharmacokinetic Properties of Rosuvastatin After Single-Dose, Oral Administration in Chinese Volunteers: A Randomized, Open-Label, Three-Way Crossover Study Li, Yunxia
2007
29 Supplement A p. 2194-2203
10 p.
artikel
193 Pharmacokinetics and Pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease Smith, William B.
2007
29 Supplement A p. 1368-1380
13 p.
artikel
194 Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: An open-label, single- and multiple-dose study James, Laura
2007
29 Supplement A p. 2082-2092
11 p.
artikel
195 Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage Kikuchi, Junko
2007
29 Supplement A p. 123-130
8 p.
artikel
196 Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years Kisicki, James C.
2007
29 Supplement A p. 1967-1979
13 p.
artikel
197 Plasma Pharmacokinetic Characteristics of Risperidone and Their Relationship to Saliva Concentrations in Children with Psychiatric or Neurodevelopmental Disorders Aman, Michael G.
2007
29 Supplement A p. 1476-1486
11 p.
artikel
198 Policy implications of drug importation Palumbo, Francis B.
2007
29 Supplement A p. 2758-2767
10 p.
artikel
199 Pompe Disease: A Continuum of Clinical Phenotypes Hagemans, Marloes
2007
29 Supplement A p. S103-S104
2 p.
artikel
200 Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children Rahman, Ateequr
2007
29 Supplement A p. 1950-1956
7 p.
artikel
201 Posaconazole: An extended-spectrum triazole antifungal agent Schiller, Daryl S.
2007
29 Supplement A p. 1862-1886
25 p.
artikel
202 Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Efficacy and Tolerability Study of Tramadol Extended Release for the Treatment of Osteoarthritis Pain in Geriatric Patients Vorsanger, Gary
2007
29 Supplement A p. 2520-2535
16 p.
artikel
203 Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease Monastero, Roberto
2007
29 Supplement A p. 2706-2709
4 p.
artikel
204 Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus Singh-Franco, Devada
2007
29 Supplement A p. 535-562
28 p.
artikel
205 Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison Ilag, Liza L.
2007
29 Supplement A p. 1254-1270
17 p.
artikel
206 Pregabalin: A novel γ-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders Tassone, Daniel M.
2007
29 Supplement A p. 26-48
23 p.
artikel
207 Prescript-assist™ probiotic-prebiotic treatment for irritable bowel syndrome: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial Bittner, Alvah C.
2007
29 Supplement A p. 1153-1160
8 p.
artikel
208 Prevalence and treatment of dyslipidemia in canadian primary care: A retrospective cohort analysis Petrella, Robert J.
2007
29 Supplement A p. 742-750
9 p.
artikel
209 Prevalence of fabry disease in a cohortof 479 unrelated patients with hypertrophic cardiomyopathy Monserrat, L.
2007
29 Supplement A p. S23-S24
2 p.
artikel
210 Prevalence of fabry disease in malepatients with chronic renal disease not receiving renal replacement therapy: Preliminary report of a multicenter study Herrero, J.A.
2007
29 Supplement A p. S21-
1 p.
artikel
211 Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid Population, 1998–2003 Morrato, Elaine H.
2007
29 Supplement A p. 183-195
13 p.
artikel
212 Progression of left ventricularhypertrophy in fabry disease is faster in patients with phosphocreatine depletion: A phosphorus-31 magnetic resonance spectroscopy study Bultas, J.
2007
29 Supplement A p. S24-
1 p.
artikel
213 Progressive development of microalbuminuria and proteinuria in males and females with fabry disease Ortiz, A.
2007
29 Supplement A p. S19-S20
2 p.
artikel
214 Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia Cappellini, Maria Domenica
2007
29 Supplement A p. 909-917
artikel
215 Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy Tisdale, James E.
2007
29 Supplement A p. 2226-2234
9 p.
artikel
216 Proton pump inhibitors and hospital discharge rates for gastrointestinal events in italy: A national ecological study Russo, Pierluigi
2007
29 Supplement A p. 751-758
8 p.
artikel
217 Psychometric Testing and Validation of the Chronic Pain Sleep Inventory Kosinski, Mark
2007
29 Supplement A p. 2562-2577
16 p.
artikel
218 Ranibizumab for the treatment of neovascular age-related macular degeneration: A review Kourlas, Helen
2007
29 Supplement A p. 1850-1861
12 p.
artikel
219 Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: A summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability Thyssen, An
2007
29 Supplement A p. 290-304
15 p.
artikel
220 Rationale for use of the fixed combination of delapril and manidipine in the treatment of hypertension in patients with diabetes mellitus Fogari, Roberto
2007
29 Supplement A p. S54-S63
10 p.
artikel
221 Recent identification of a fabry kindred in rural Newfoundland, Canada Murphy, S.
2007
29 Supplement A p. S25-
1 p.
artikel
222 Recognition and treatment of hyponatremia in acutely ill hospitalized patients Patel, Gourang P.
2007
29 Supplement A p. 211-229
19 p.
artikel
223 Reducing the Risk for Breast Cancer Recurrence After Completion of Tamoxifen Treatment in Postmenopausal Women Jahanzeb, Mohammad
2007
29 Supplement A p. 1535-1547
13 p.
artikel
224 Relationship between cardiac and kidneyinvolvement in fabry patients presenting with a classic phenotype Strotmann, J.
2007
29 Supplement A p. S22-
1 p.
artikel
225 Relationship between chronic renal disease, blood pressure, and left ventricular hypertrophy in males and females with Fabry disease Ortiz, A.
2007
29 Supplement A p. S21-S22
2 p.
artikel
226 Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: A single-dose, randomized, open-label, crossover study in healthy subjects Henney III, Herbert R.
2007
29 Supplement A p. 661-669
9 p.
artikel
227 Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension Sharma, Akhilesh
2007
29 Supplement A p. 2667-2676
10 p.
artikel
228 Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in korean adults with mild to moderate hypertension Kim, Sang-Hyun
2007
29 Supplement A p. 1924-1936
13 p.
artikel
229 Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes Zieve, Franklin J.
2007
29 Supplement A p. 74-83
10 p.
artikel
230 RETRACTED: Prevention of pain due to injection of propofol with IV administration of lidocaine 40 mg + metoclopramide 2.5, 5, or 10 mg or saline: A randomized, double-blind study in Japanese adult surgical patients Fujii, Yoshitaka
2007
29 Supplement A p. 856-861
artikel
231 Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers Wang, Zaiqi
2007
29 Supplement A p. 1098-1106
9 p.
artikel
232 Right ventricular involvement in Fabry disease Dostalova, G.
2007
29 Supplement A p. S23-
1 p.
artikel
233 Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: A pooled analysis of thirty clinical trials Winkler, Karl
2007
29 Supplement A p. 1987-2000
14 p.
artikel
234 Role of patient experience in atypical antipsychotic adherence: A retrospective data analysis Vanelli, Mark
2007
29 Supplement A p. 2768-2773
6 p.
artikel
235 Role of recombinant human growth hormone in HIV-associated wasting and cachexia: Pathophysiology and rationale for treatment Gelato, Marie
2007
29 Supplement A p. 2269-2288
20 p.
artikel
236 Rotavirus live, oral, pentavalent vaccine Tom-Revzon, Catherine
2007
29 Supplement A p. 2724-2737
14 p.
artikel
237 Simulated Comparison of the Pharmacodynamics of Ciprofloxacin and Levofloxacin Against Pseudomonas aeruginosa Using Pharmacokinetic Data from Healthy Volunteers and 2002 Minimum Inhibitory Concentration Data Burgess, David S.
2007
29 Supplement A p. 1421-1427
7 p.
artikel
238 Single-Dose Intravenous Tramadol for Acute Migraine Pain in Adults: A Single-Blind, Prospective, Randomized, Placebo-Controlled Clinical Trial Alemdar, Murat
2007
29 Supplement A p. 1441-1447
7 p.
artikel
239 Sitagliptin phosphate: A DPP-4 inhibitor for the treatment of type 2 diabetes mellitus Zerilli, Tina
2007
29 Supplement A p. 2614-2634
21 p.
artikel
240 Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: Results of two randomized studies in patients with Parkinson's disease Tompson, Debra J.
2007
29 Supplement A p. 2654-2666
13 p.
artikel
241 Sunitinib Malate for the Treatment of Metastatic Renal Cell Carcinoma and Gastrointestinal Stromal Tumors Adams, Val R.
2007
29 Supplement A p. 1338-1353
16 p.
artikel
242 Telbivudine for the management of chronic hepatitis B virus infection Matthews, S. James
2007
29 Supplement A p. 2635-2653
19 p.
artikel
243 The cycle of migraine: Patients' quality of life during and between migraine attacks Freitag, Frederick G.
2007
29 Supplement A p. 939-949
artikel
244 The Effect of Simvastatin on Erythrocyte Membrane Fluidity During Oxidative Stress Induced by Cardiopulmonary Bypass: A Randomized Controlled Study Coccia, Raffaella
2007
29 Supplement A p. 1706-1717
12 p.
artikel
245 The effects of combination treatment with a long-acting β2-agonist and a corticosteroid on salivary flow rate, secretory immunoglobulin a, and oral health in children and adolescents with moderate asthma: a 1-month, single-blind clinical study Sag, Cigdem
2007
29 Supplement A p. 2236-2242
7 p.
artikel
246 The Enhancement of Coping Skills and Compliance to Treatment in Adolescents with a Chronic Serious Disease Last, Bob F.
2007
29 Supplement A p. S107-S108
2 p.
artikel
247 The history and contemporary challenges of the US Food and Drug Administration Borchers, Andrea T.
2007
29 Supplement A p. 1-16
16 p.
artikel
248 The Quality of Reporting of Randomized Controlled Trials of Traditional Chinese Medicine: A Survey of 13 Randomly Selected Journals from Mainland China Wang, Gang
2007
29 Supplement A p. 1456-1467
12 p.
artikel
249 Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review Bordeleau, Louise
2007
29 Supplement A p. 230-241
12 p.
artikel
250 Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance Luna, Beatriz
2007
29 Supplement A p. 2309-2318
10 p.
artikel
251 Titration patterns with rosuvastatin as compared with other statins in clinical practice: A retrospective observational cohort study using an electronic medical record database Fox, Kathleen M.
2007
29 Supplement A p. 2385-2394
10 p.
artikel
252 Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension Poldermans, Don
2007
29 Supplement A p. 279-289
11 p.
artikel
253 Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial Barnett, Anthony H.
2007
29 Supplement A p. 2333-2348
16 p.
artikel
254 Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study Cowie, Robert L.
2007
29 Supplement A p. 1390-1402
13 p.
artikel
255 Topiramate prescribing patterns among medicaid patients: Diagnosis, comorbidities, and dosing Poston, Sara
2007
29 Supplement A p. 504-518
15 p.
artikel
256 Transdermal Buprenorphine Patches Applied in a 4-Day Regimen Versus a 3-Day Regimen: A Single-Site, Phase III, Randomized, Open-Label, Crossover Comparison Likar, Rudolf
2007
29 Supplement A p. 1591-1606
16 p.
artikel
257 Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder—A preliminary tolerability and efficacy study Quintana, Humberto
2007
29 Supplement A p. 1168-1177
10 p.
artikel
258 Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: A 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial Berger, Richard
2007
29 Supplement A p. 1086-1097
12 p.
artikel
259 Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma Corren, Jonathan
2007
29 Supplement A p. 823-843
artikel
260 Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension Philipp, Thomas
2007
29 Supplement A p. 563-580
18 p.
artikel
261 Undertreatment of Anemia in Patients with Chronic Kidney Disease in the United States: Analysis of National Outpatient Survey Data Rasu, Rafia S.
2007
29 Supplement A p. 1524-1534
11 p.
artikel
262 Use of a Bayesian Network to Predict the Nighttime Intraocular Pressure Peak from Daytime Measurements Nordmann, Jean-Philippe
2007
29 Supplement A p. 1751-1760
10 p.
artikel
263 Use of patient-reported sleep measures in clinical trials of pain treatment: a literature review and synthesis of current sleep measures and a conceptual model of sleep disturbance in pain Cole, Jason C.
2007
29 Supplement A p. 2580-2588
9 p.
artikel
264 Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: Insulin pump therapy versus multiple daily injections Bode, Bruce W.
2007
29 Supplement A p. S135-S144
10 p.
artikel
265 Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid Penfold, Robert B.
2007
29 Supplement A p. 359-370
12 p.
artikel
266 Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state medicaid program: A retrospective, cross-sectional, descriptive, database analysis Khanna, Rahul
2007
29 Supplement A p. 2456-2467
12 p.
artikel
267 Utilization of, and Adherence to, Drug Therapy Among Medicaid Beneficiaries with Congestive Heart Failure Bagchi, Ann D.
2007
29 Supplement A p. 1771-1783
13 p.
artikel
268 Warfarin metabolism and anticoagulant effect: A prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactions Muszkat, Mordechai
2007
29 Supplement A p. 427-437
11 p.
artikel
                             268 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland